Programmbereich Chronische Lungenerkrankungen
DZL Labor Experimentelle Mikrobiomforschung
Mission Projekte
Drittmittel
Methoden
Publikationen
Mitarbeiter/innen
Publikationen
2023
Chen, J, Wang, X, Schmalen, A, Haines, S, Wolff, M, Ma, H, Zhang, H, Stoleriu, MG, Nowak, J, Nakayama, M, Bueno, M, Brands, J, Mora, AL, Lee, JS, Krauss-Etschmann, S, Dmitrieva, A, Frankenberger, M, Hofer, TP, Noessner, E, Moosmann, A, Behr, J, Milger, K, Deeg, CA, Staab-Weijnitz, CA, Hauck, SM, Adler, H, Goldmann, T, Gaede, KI, Behrends, J, Kammerl, IE & Meiners, S 2023, 'Antiviral CD8+ T cell immune responses are impaired by cigarette smoke and in COPD', The European respiratory journal, Jg. 62, Nr. 2, 2201374. https://doi.org/10.1183/13993003.01374-2022
GEN-COVID Multicenter Study Group 2023, 'CYP19A1 mediates severe SARS-CoV-2 disease outcome in males', Cell reports. Medicine, S. 101152. https://doi.org/10.1016/j.xcrm.2023.101152
2022
Ehrhardt, B, Krauss-Etschmann, S, Schramm, J, Kovacevic, D, El-Merhie, N, Roeder, T & Bossen, J 2022, 'Airway remodeling: The Drosophila model permits a purely epithelial perspective', Frontiers in Allergy, Jg. 3, S. 876673. https://doi.org/10.3389/falgy.2022.876673
Pfeiffer, S, Jatzlauk, G, Lund, JV, Boateng, E, Kovacevic, D, N Hylkema, M, Bartel, S, Schloter, M & Krauss-Etschmann, S 2022, 'Oral application of vancomycin alters murine lung microbiome and pulmonary immune responses', Immunity, inflammation and disease, Jg. 10, Nr. 8, S. e675. https://doi.org/10.1002/iid3.675
2020
Lund, J, Kovacevic, D, Schloter, M & Krauss-Etschmann, S 2020, 'Rolle der mikrobiellen Darm-Lungen-Achse für die Lungengesundheit: Mikrobiom – Darm-Lungen-Achse – Lungenerkrankungen – bakterielle Metabolite', Pädiatrische Praxis, Jg. 93 / 3, S. 444-452.
Pfeiffer, S, Herzmann, C, Gaede, KI, Kovacevic, D, Krauss-Etschmann, S & Schloter, M 2021, 'Different responses of the oral, nasal and lung microbiomes to cigarette smoke', Thorax. https://doi.org/10.1136/thoraxjnl-2020-216153